Annual Financial Report
6 September 2022
LEI: 213800J4UVB5OWG8VX82
Dechra® Pharmaceuticals PLC
(Dechra or the Company)
Availability of 2022 Annual Report and Accounts
The 2022 Annual Report and Accounts is now available to view at www.dechra.com .
The following documents are scheduled to be mailed to registered shareholders of the Company on 19 September 2022:
· 2022 Annual Report and Accounts
· Notice of the 2022 Annual General Meeting; and
· Proxy Form for the 2022 Annual General Meeting.
In accordance with Listing Rule 9.6.1 a copy of each of these documents will be submitted to the National Storage Mechanism and will be available for viewing shortly after posting.
For further information, please contact:
Melanie Hall, Company Secretary
Dechra Pharmaceuticals PLC
Telephone number: 01606 814730
About Dechra
Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide.
For more information please visit: www.dechra.com
Trademarks
Trademarks appear throughout this document in italics. Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
COMPANIES COVERED:
Latest directors dealings
- 3 hours ago Legal & General Group
- 4 hours ago Baillie Gifford Japan Trust
- 7 hours ago British Land Company
- 7 hours ago Premier Miton Global Renewables Trust
- 7 hours ago NATWEST GROUP